Reflect Scientific, Inc.
RSCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 73.8% | -47.1% | -27.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 29.7% | 55.2% | 59.7% | 68.6% |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 12.9% | -37.6% | 7.2% | 31.4% |
| Net Income | $0 | -$0 | $0 | $0 |
| % Margin | 9% | -42.5% | 4.4% | 33.4% |
| EPS Diluted | 0.002 | -0.005 | 0.001 | 0.011 |
| % Growth | 137% | -640% | -91% | – |
| Operating Cash Flow | – | -$0 | -$0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$0 | -$0 | $0 |